Alnylam Pharmaceuticals at BIO CEO & Investor Conference Transcript - Thomson StreetEvents

The Premium Business Information Source™

Thomson StreetEvents

Title:	Alnylam Pharmaceuticals at BIO CEO & Investor Conference Transcript
Price:	$54.00
Publication Date:	Feb 11, 2008
Source:	Thomson StreetEvents
Report Type:	Transcript
Abstract:	Final Transcript of ALNY presentation, 11-Feb-08 1:15pm ET
Brief Excerpt:	...Okay. Our next presenting company is Alnylam Pharmaceuticals of Cambridge, Massachusetts. Alnylam Pharmaceuticals, a leader in RNAi therapeutics, is a biopharmaceutical company developing novel therapeutics based on a breakthrough in biology known as RNA interference. Using RNAi, Alnylam has built a product platform to develop a deep pipeline of drug products to treat a wide array of important diseases. Presenting for Alnylam is Barry Greene, President and Chief Operating Officer. There will be Q&A session following his presentation. ...
Word Count:	5504
Length:	8 Pages
Ticker:	ALNY
Time:	1:15pm ET
Related Report(s):	Alnylam Pharmaceuticals Q2 2008 Earnings Conference Call Summary: $54.00 Edited Brief of ALNY earnings conference call or presentation, 6-Aug-08 4:30pm ET Alnylam Pharmaceuticals Q2 2008 Earnings Conference Call Transcript: $54.00 Final Transcript of ALNY earnings conference call or presentation, 6-Aug-08 4:30pm ET Alnylam Pharmaceuticals Conference Call to Discuss Takeda Alliance Transcript: $54.00 Final Transcript of ALNY M&A conference call or presentation, 27-May-08 8:30am ET Alnylam Pharmaceuticals Q1 2008 Earnings Conference Call Transcript: $54.00 Final Transcript of ALNY earnings conference call or presentation, 8-May-08 4:30pm ET Alnylam Pharmaceuticals at Morgan Stanley 2008 Global Healthcare Unplugged Conference Transcript: $54.00 Final Transcript of ALNY presentation, 2-May-08 9:50am ET Conference Call to discuss GlaxoSmithKline and Regulus Therapeutics Strategic Alliance Summary: $54.00 Edited Brief of ALNY M&A conference call or presentation, 17-Apr-08 8:00am ET Conference Call to discuss GlaxoSmithKline and Regulus Therapeutics Strategic Alliance Transcript: $54.00 Final Transcript of ALNY M&A conference call or presentation, 17-Apr-08 8:00am ET Alnylam Pharmaceuticals R&D Day Transcript: $54.00 Final Transcript of ALNY conference call or presentation, 6-Mar-08 9:00am ET
Format:	Adobe Acrobat
Free Sample:	Click Here to Download

Enter the keyword(s) which you would like to search for within this document and click "Search"



Price: $54.00

Looking For Something Else?

Search the Alacra Store

Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool. <br/>Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

about us

public company index

private company index

Copyright © 2008 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.